Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation.
Study Goal
The researchers aimed to determine how guar gum affects gut microbiota activity and the pathogenesis of inflammatory bowel disease (IBD), specifically its role in colitis development.
Results Summary
Guar gum increased susceptibility to colonic inflammation, exacerbated colitis symptoms, and altered gut microbiota composition, favoring the accumulation of metabolites like succinate and lactate. Pre-treatment with antibiotics or recombinant IL-18 attenuated colitis, suggesting microbiota and IL-18 play key roles in guar gum's inflammatory effects.
Population
Mice (specifically, DSS-induced colitis model)
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
guar gum containing diet (GuD) | increase | colonic inflammation | mice | - | increased the susceptibility to | #1 |
guar gum containing diet (GuD) | increase | colitis severity | GuD-fed group | - | exhibited severe colitis upon dextran sulfate sodium (DSS) administration | #2 |
guar gum containing diet (GuD) | decrease | body weight | GuD-fed group | - | reduced | #3 |
guar gum containing diet (GuD) | decrease | colon length | GuD-fed group | - | shortening of | #4 |
guar gum containing diet (GuD) | increase | pro-inflammatory markers in serum [serum amyloid A (SAA), lipocalin 2 (Lcn2)] | GuD-fed group | - | elevated levels of | #5 |
guar gum containing diet (GuD) | increase | pro-inflammatory markers in colon (Lcn2) | GuD-fed group | - | elevated levels of | #6 |
guar gum containing diet (GuD) | increase | colonic architecture | GuD-fed group | - | extensive disruption of | #7 |
guar gum containing diet (GuD) | decrease | colitis | GuD-fed group pre-treated with antibiotics | - | amelioration of | #8 |
guar gum | increase | Actinobacteriota, specifically Bifidobacterium | mice | - | primarily enriches | #9 |
guar gum | change | multiple genera belonging to phyla Bacteroidota and Firmicutes | mice | - | altered | #10 |
guar gum containing diet (GuD) | increase | intermediary metabolites succinate and lactate | GuD-fed mice | - | favored luminal accumulation of | #11 |
guar gum containing diet (GuD) | decrease | colonic IL-18 | GuD-fed group | - | decreased | #12 |
guar gum containing diet (GuD) | decrease | tight junction markers | GuD-fed group | - | decreased | #13 |
guar gum containing diet (GuD) | decrease | colitis | GuD-fed mice pre-treated with recombinant IL-18 | - | displayed attenuated | #14 |
With an increasing interest in dietary fibers (DFs) to promote intestinal health and the growth of beneficial gut bacteria, there is a continued rise in the incorporation of refined DFs in processed foods. It is still unclear how refined fibers, such as guar gum, affect the gut microbiota activity and pathogenesis of inflammatory bowel disease (IBD). Our study elucidated the effect and underlying mechanisms of guar gum, a fermentable DF (FDF) commonly present in a wide range of processed foods, on colitis development. We report that guar gum containing diet (GuD) increased the susceptibility to colonic inflammation. Specifically, GuD-fed group exhibited severe colitis upon dextran sulfate sodium (DSS) administration, as evidenced by reduced body weight, diarrhea, rectal bleeding, and shortening of colon length compared to cellulose-fed control mice. Elevated levels of pro-inflammatory markers in both serum [serum amyloid A (SAA), lipocalin 2 (Lcn2)] and colon (Lcn2) and extensive disruption of colonic architecture further affirmed that GuD-fed group exhibited more severe colitis than control group upon DSS intervention. Amelioration of colitis in GuD-fed group pre-treated with antibiotics suggest a vital role of intestinal microbiota in GuD-mediated exacerbation of intestinal inflammation. Gut microbiota composition and metabolite analysis in fecal and cecal contents, respectively, revealed that guar gum primarily enriches Actinobacteriota, specifically Bifidobacterium. Guar gum also altered multiple genera belonging to phyla Bacteroidota and Firmicutes. Such shift in gut microbiota composition favored luminal accumulation of intermediary metabolites succinate and lactate in the GuD-fed mice. Colonic IL-18 and tight junction markers were also decreased in the GuD-fed group. Importantly, GuD-fed mice pre-treated with recombinant IL-18 displayed attenuated colitis. Collectively, unfavorable changes in gut microbiota activity leading to luminal accumulation of lactate and succinate, reduced colonic IL-18, and compromised gut barrier function following guar gum feeding contributed to increased colitis susceptibility.